Automated And Closed Cell Therapy Processing Systems Market Size Is Expected To Reach USD 3.66 Billion By 2030


 San Francisco, 29 Aug 2023: The Report Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion, Apheresis), By Type, By Scale, By Region, And Segment Forecasts, 2023 - 2030

The global automated and closed cell therapy processing systems market size is expected to reach USD 3.66 billion by 2030, registering a CAGR of 18.2% over the forecast period, according to a new report by Grand View Research, Inc. Market players are making significant investments to introduce an automated process system as a viable strategy to accelerate their cell therapy product development process, thereby driving market growth.

The expansion of GMP manufacturing facilities further supports the implementation of automated processes for commercial operations. In addition, the wide application scope of single-use disposable tubing sets and bags also facilitates automated processing of therapy R&D. Moreover, key entities are undertaking strategies for effective implementation of automation technology in manufacturing labs resulting in lucrative revenue growth.

The rapid growth in the cases of COVID-19 is anticipated to play a vital role in the market growth. The pandemic has led to an increased focus on automation technologies. Moreover, the companies emphasized raising funds with an aim to develop advanced therapies and regenerative medicines to fight against COVID-19. Industry players are also concentrating on the development of new therapies, such as stem cell therapy, natural killer cell therapy, exosomes, and others.

Access Research Report of Automated And Closed Cell Therapy Processing Systems Market https://www.grandviewresearch.com/industry-analysis/automated-closed-cell-therapy-processing-systems-market-report

Automated And Closed Cell Therapy Processing Systems Market Report Highlights

  • The cell expansion workflow segment accounted for the maximum revenue share of the global market in 2022. An increasing focus on achieving high output yield has resulted in the high revenue share of the segment
  • The cell separation workflow segment is estimated to register the fastest CAGR during the forecast period due to an increasing number of stem cell therapy R&D programs
  • Automated apheresis and cryopreservation workflow are also expected to register considerable growth rates over the forecast period due to the growing emphasis on preservation and sorting for cell therapies
  • The non-stem cellular therapies segment dominated the market in 2022 and will expand further at a steady CAGR over the forecast period. The success of CAR T therapies is one of the major driving forces of this segment
  • The pre-commercial/R&D scale segment captured the maximum revenue share in 2022 due to the increased number of research and innovation activities for new drug & therapy developments
  • North America emerged as the highest revenue-generating region in 2022 owing to the presence of a large number of approved therapies in the region influencing the market players to invest in more R&D programs
  • Companies are undertaking strategic initiatives, such as partnerships and collaborations, to gain higher market shares. For instance, in January 2021, Fresenius Kabiformed a joint venture with Bio-Techne to launch ScaleReady, to develop a scalable and versatile therapy manufacturing platform

Automated And Closed Cell Therapy Processing Systems Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 1,138.7 million

Revenue forecast in 2030

USD 3.66 billion

Growth rate

CAGR of 18.2% from 2023 to 2030

Base year for estimation

2022

Historical data

2018 - 2021

Forecast period

2023 - 2030

List of Key Players in Automated And Closed Cell Therapy Processing Systems Market

  • MiltenyiBiotec
  • Lonza
  • Fresenius Kabi
  • Cytiva (Danaher Corp.)
  • BioSpherix, Ltd.
  • Terumo Corporation
  • Sartorius AG
  • ThermoGenesis Holdings, Inc.
  • Cellares Inc.
  • Thermo Fisher Scientific, Inc.

Access Press Release of Automated And Closed Cell Therapy Processing Systems Market @ https://www.grandviewresearch.com/press-release/global-automated-closed-cell-therapy-processing-systems-market

 

Comments

Popular posts from this blog

U.K. Point Of Sale Software Market To Expand Industry Growth At USD 1.05 Billion By 2028

Gas Detection Equipment Market Anticipated To Expand At A CAGR 9.7% From 2021 To 2028